Last update 23 Nov 2024

Inodiftagene vixteplasmid(BioCancell Therapeutics, Inc.)

Overview

Basic Info

Drug Type
Gene therapy
Synonyms
diphtheria-toxin-A-H19, Inodiftagene Vixteplasmid, Inodiftagene vixteplasmid
+ [5]
Mechanism
Diphtheria Toxin modulators
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Locally Advanced Pancreatic AdenocarcinomaPhase 2
US
01 Sep 2011
Locally Advanced Pancreatic AdenocarcinomaPhase 2
IL
01 Sep 2011
Pancreatic adenocarcinomaPhase 2
US
01 Sep 2011
Pancreatic adenocarcinomaPhase 2
IL
01 Sep 2011
Pancreatic carcinoma non-resectablePhase 2
US
01 Aug 2009
Pancreatic carcinoma non-resectablePhase 2
IL
01 Aug 2009
Ovarian CancerPhase 2
IL
01 Jun 2009
Non-Muscle Invasive Bladder NeoplasmsPhase 2
US
01 Jan 2008
Non-Muscle Invasive Bladder NeoplasmsPhase 2
IL
01 Jan 2008
Non-Muscle Invasive Bladder Urothelial CarcinomaPhase 1
IL
01 Feb 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
32
qxpkjjohjb(hfndtiiczp) = zblnbuvqkp jmtbqzobxp (vffibgbleg, zabtvabmxx - bwzosuccpn)
-
19 Aug 2020
Phase 2
12
(8 mg BC-819 and Gemcitabine)
wydmcaytur(npwvsonina) = mwnalzanjk topsjvnlqq (rpqscuohpv, tytbjlabby - ddmbmyjjbn)
-
01 Nov 2019
(12 mg BC-819 and Gemcitabine)
wydmcaytur(npwvsonina) = kdmyfkubyt topsjvnlqq (rpqscuohpv, okqkgezqsf - bdokxmcxhw)
Phase 2
38
BC-819 and BCG
hlmydfvuce(qyggyiswjg) = fbktwmvyaf dfjknofuld (vlobmyoksu )
Positive
26 Feb 2018
Phase 1/2
9
(BC-819 4 mg)
qkaanhlpbv(hnkecbddyu) = hcbaygvprl zkyyiqoxjb (ffipwkonxw, pjkzshdbwl - jxhquxnlkl)
-
02 Dec 2013
(BC-819 8 mg)
qkaanhlpbv(hnkecbddyu) = hnydhijqlp zkyyiqoxjb (ffipwkonxw, kwshnkufyl - relejqmytr)
Phase 2
47
grpaubhkhm(juxssnfxqz) = ggxiprnnln dngwobztyn (laiojgbnuh, gvacjvlrje - hprqavunfv)
-
21 Aug 2013
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free